Wordt geladen...
Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge
Objective: The aim of this observational study was to determine the optimal timing of interleukin-6 receptor inhibitor (IL6ri) administration for coronavirus disease 2019 (COVID-19). Methods: Patients with COVID-19 were given an IL6ri (sarilumab or tocilizumab) based on iteratively reviewed guidelin...
Bewaard in:
Hoofdauteurs: | , , , , , , , , , , , , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Elsevier
2020-10-01
|
Reeks: | International Journal of Infectious Diseases |
Onderwerpen: | |
Online toegang: | http://www.sciencedirect.com/science/article/pii/S1201971220305683 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|